Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
155.32B
Market cap155.32B
Price-Earnings ratio
35.58
Price-Earnings ratio35.58
Dividend yield
6.40%
Dividend yield6.40%
Average volume
41.12M
Average volume41.12M
High today
$27.39
High today$27.39
Low today
$26.94
Low today$26.94
Open price
$27.12
Open price$27.12
Volume
15.91M
Volume15.91M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.58
52 Week low$23.58

Stock Snapshot

The current Pfizer(PFE) stock price is $27.25, with a market capitalization of 155.32B. The stock trades at a price-to-earnings (P/E) ratio of 35.58 and offers a dividend yield of 6.40%.

On 2026-08-18, Pfizer(PFE) stock traded between a low of $26.94 and a high of $27.39. Shares are currently priced at $27.25, which is +1.2% above the low and -0.5% below the high.

The Pfizer(PFE)'s current trading volume is 15.91M, compared to an average daily volume of 41.12M.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

PFE News

Nasdaq 5h
Warren Buffett and Greg Abel Keep Overlooking This Stock -- but It's One of the Most Berkshire-Ready Picks on the Market

Key Points Its current dividend yield is sizeable, and based on a dividend with more resiliency than the market’s presuming. Most drugs have more of a defensi...

Warren Buffett and Greg Abel Keep Overlooking This Stock -- but It's One of the Most Berkshire-Ready Picks on the Market
Simply Wall St 22h
Albert Bourla Bought 9.6% More Shares In Pfizer

Those following along with Pfizer Inc. ( ) will no doubt be intrigued by the recent purchase of shares by Albert Bourla, Chairman of the Board & CEO of the comp...

Albert Bourla Bought 9.6% More Shares In Pfizer
TipRanks 24h
Pfizer Advances Early Obesity Drug PF-08653944 With Phase 1 Study Completion

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

Analyst ratings

62%

of 29 ratings
Buy
31%
Hold
62.1%
Sell
6.9%

More PFE News

Simply Wall St 2d
Pfizer Stock And 2 AI Healthcare Picks Built Around Productivity Growth

With global bond yields high and borrowing costs less forgiving, capital is flowing toward companies that can raise productivity rather than just cut expenses....

Pfizer Stock And 2 AI Healthcare Picks Built Around Productivity Growth
Simply Wall St 3d
Pfizer Stock Looks Fully Valued At Today’s Price

Pfizer stock has returned roughly 28.4% less over the past five years, yet the current valuation screens as somewhat expensive on market multiples and only mixe...

Pfizer Stock Looks Fully Valued At Today’s Price
TipRanks 3d
Pfizer Insider Buying Surge and Vaccine Wins Ignite Buzz

Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Claim 55% Off TipRanks Unlock powerful investing too...

TipRanks 4d
Opko Health Expands Royalty-Backed Long-Term Note Financing

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

TipRanks 4d
Pfizer CEO Buys $1 Million of Company Stock

Albert Bourla, CEO of pharmaceutical giant Pfizer (PFE), has made his first-ever open-market purchase of company stock, buying $1 million worth of shares. Claim...

TipRanks 4d
Pfizer’s Korean Paxlovid Study Signals Ongoing Value in High‑Risk COVID Market

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident inv...

TipRanks 4d
Valneva Stock Soars Over 20% On Lyme Disease Vaccine Hopes

Shares in biotech Valneva (VALN) soared over 20% in early trading today after it and partner Pfizer (PFE) as it moved closer to bringing its Lyme disease vaccin...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.